Similar articles for PMID: 22009203

Year	Number of Results
2000	2
2002	1
2004	1
2005	2
2006	3
2007	2
2008	5
2009	2
2010	4
2011	10
2012	8
2013	10
2014	5
2015	9
2016	10
2017	10
2018	6
2019	8
2020	3
2021	3
2022	4
2023	1
2024	0

1

Lao VV, Grady WM. Lao VV, et al. Nat Rev Gastroenterol Hepatol. 2011 Oct 18;8(12):686-700. doi: 10.1038/nrgastro.2011.173. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22009203 Free PMC article. Review.

2

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

Okugawa Y, Grady WM, Goel A. Okugawa Y, et al. Gastroenterology. 2015 Oct;149(5):1204-1225.e12. doi: 10.1053/j.gastro.2015.07.011. Epub 2015 Jul 26. Gastroenterology. 2015. PMID: 26216839 Free PMC article. Review.

3

Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?

Bae JM, Rhee YY, Kim KJ, Wen X, Song YS, Cho NY, Kim JH, Kang GH. Bae JM, et al. Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25. Hum Pathol. 2016. PMID: 26520418

4

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.

Kim JH, Bae JM, Cho NY, Kang GH. Kim JH, et al. Oncotarget. 2016 Mar 22;7(12):14095-111. doi: 10.18632/oncotarget.7374. Oncotarget. 2016. PMID: 26883113 Free PMC article.

5

Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.

An B, Kondo Y, Okamoto Y, Shinjo K, Kanemitsu Y, Komori K, Hirai T, Sawaki A, Tajika M, Nakamura T, Yamao K, Yatabe Y, Fujii M, Murakami H, Osada H, Tani T, Matsuo K, Shen L, Issa JP, Sekido Y. An B, et al. Int J Cancer. 2010 Nov 1;127(9):2095-105. doi: 10.1002/ijc.25225. Int J Cancer. 2010. PMID: 20131317 Free article.

6

Colorectal cancer: epigenetic alterations and their clinical implications.

Puccini A, Berger MD, Naseem M, Tokunaga R, Battaglin F, Cao S, Hanna DL, McSkane M, Soni S, Zhang W, Lenz HJ. Puccini A, et al. Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):439-448. doi: 10.1016/j.bbcan.2017.09.003. Epub 2017 Sep 20. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28939182 Free PMC article. Review.

7

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.

Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, Imai K, Sugai T, Shen L, Issa JP, Shinomura Y, Tokino T, Toyota M. Suzuki H, et al. Carcinogenesis. 2010 Mar;31(3):342-9. doi: 10.1093/carcin/bgp179. Epub 2009 Jul 28. Carcinogenesis. 2010. PMID: 19638426

8

Epigenetics and colorectal cancer pathogenesis.

Bardhan K, Liu K. Bardhan K, et al. Cancers (Basel). 2013 Jun 5;5(2):676-713. doi: 10.3390/cancers5020676. Cancers (Basel). 2013. PMID: 24216997 Free PMC article.

9

Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.

Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim HC, Chun HK, Grady WM, Kim YS. Kim YH, et al. Ann Surg Oncol. 2011 Aug;18(8):2338-47. doi: 10.1245/s10434-011-1573-y. Epub 2011 Feb 5. Ann Surg Oncol. 2011. PMID: 21298349 Free PMC article.

10

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.

Bae JM, Kim JH, Kang GH. Bae JM, et al. Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23. Histol Histopathol. 2013. PMID: 23341177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year